- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Egypt-focused Centamin (LSE:CLY,TSX:CEE) was up 4 percent in London after the company released production numbers for 2013, The Guardian reported on Monday.
Egypt-focused Centamin (LSE:CEY,TSX:CEE) was up 4 percent in London after the company released production numbers for 2013, The Guardian reported on Monday.
As quoted in the market news:
[D]espite the violence and uncertainty about its right to mine at its Sukari site, the company has reported total output of 356,943 ounces of gold for 2013, above October’s guidance of 320,000 ounces. Chairman Josef El-Raghy said:
We look forward to delivering a further successive year of growth in 2014 as the plant expansion drives the continued ramp-up towards our 450,000 to 500,000 ounce per annum long-term target.
Read the full article in The Guardian’s MarketForcesLive blog
Â
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â